New Frontiers in Treating Metastatic Cervical Cancer From Revolutionary Molecules to Clinical Therapies
ESGO eAcademy. Presenters F. 10/23/21; 346489

Ignace Vergote

Christian Marth

Isabelle Ray-Coquard

Mansoor Raza Mirza

Domenica Lorusso
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Click here to create a free account.
Access to Premium content is currently a membership benefit.
Click here to join ESGO or renew your membership.
You may also access ESGO content "anytime, anywhere" with the FREE ESGO eAcademy App for iOS and Android.
Click here to create a free account.
Access to Premium content is currently a membership benefit.
Click here to join ESGO or renew your membership.
You may also access ESGO content "anytime, anywhere" with the FREE ESGO eAcademy App for iOS and Android.
About this activity
Discussion Forum (0)
Chair: Ignace Vergote (Belgium)
15:00-15:05 Introduction by Ignace Vergote (Belgium)
15:05-15:20 Perspectives on current treatment landscape for r/m CC by Christian Marth (Austria), Ignace Vergote (Belgium)
15:20-15:35 Experts discuss future treatment modalities for r/m CC byIsabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)
15:35-15:50 Can ADCs change r/m CC treatment landscape? by Domenica Lorusso (Italy), Ignace Vergote (Belgium)
15:50-16:00 Live Q&A
Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com.
15:00-15:05 Introduction by Ignace Vergote (Belgium)
15:05-15:20 Perspectives on current treatment landscape for r/m CC by Christian Marth (Austria), Ignace Vergote (Belgium)
15:20-15:35 Experts discuss future treatment modalities for r/m CC byIsabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)
15:35-15:50 Can ADCs change r/m CC treatment landscape? by Domenica Lorusso (Italy), Ignace Vergote (Belgium)
15:50-16:00 Live Q&A
Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}